Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997;75(2):283-6.
doi: 10.1038/bjc.1997.46.

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

C Bain  1 , Y Merrouche, I Puisieux, J Y Blay, S Negrier, V Bonadona, C Lasset, F Lanier, A Duc, L Gebuhrer, T Philip, M C Favrot
Affiliations
Free PMC article

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma

C Bain et al. Br J Cancer. 1997.
Free PMC article

Abstract

HLA phenotypes were characterized for 79 patients with metastatic renal cell carcinoma treated with interleukin 2 (IL-2). HLA-A32 was associated with a clinical response (P = 0.025). The frequency of HLA-A3 and/or A32 was higher among responders than non-responders (P = 0.008). Thus, these results suggest that, in vivo, IL-2 may enhance cellular-mediated immunity against a tumour antigen and that some MHC molecules are more efficient than others for endogenous tumour antigen presentation.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 1975 Jun;54(6):1283-6 - PubMed
    1. Lancet. 1964 Dec 5;2(7371):1207-9 - PubMed
    1. Cancer Res. 1983 May;43(5):2330-3 - PubMed
    1. N Engl J Med. 1987 Apr 9;316(15):889-97 - PubMed
    1. N Engl J Med. 1987 Apr 9;316(15):898-905 - PubMed

Publication types